Circulating stem cell factor in patients with chronic idiopathic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 1, 2003, Pages 79-81

  Asero, Riccardo ^a,d   Tedeschi, Alberto ^b   Lorini, Maurizio ^b   Gerosa, Maria ^c   Meroni, Pierluigi ^c   Riboldi, Piersandro ^c  

^a CLINICA SAN CARLO   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Ospedale 21   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE AGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; STEM CELL FACTOR;

ARTICLE; CHRONIC URTICARIA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTAMINE RELEASE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TIME SERIES ANALYSIS;

EID: 0041343169     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62063-7     Document Type: Article

References (24)

1. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological marker in chronic idiopathic urticaria: a clinical, immunological, and histological evaluation. Br J Dermatol. 1986;114:583-590.
2. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213-217.
3. Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy. 1991;21:695-704.
4. Greaves MW. Chronic urticaria. N Engl J Med. 1995;332:1767-1772.
5. Greaves MW, O'Donnell B. Urticaria causes and treatment. Int J Immunopathol Pharmacol. 1997;99:461-465.
6. Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy. 2001;31:1105-1110.
7. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599-1604.
8. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461-465.
9. Fiebiger E, Maurer D, Holub H, et al. Serum IgG autoantibodies directed against the alpha chain of FcεRI, a selective marker and pathogenic factor for a distinct subset of chronic urticaria patients? J Clin Invest. 1995;96:2606-2612.
10. Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA. Characteristics of histamine releasing activity in patients with chronic idiopathic urticaria. J Allergy Clin Immunol. 1996;98:89-98.
11. Kaplan AP. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179.
12. Nickel R, Beck LA, Stellato C, Schleimer RP. Chemokines and allergic disease. J Allergy Clin Immunol. 1999;104:723-742.
13. Kaplan AP. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol. 2001;124:423-431.
14. Valent P. The riddle of the mast cell: kit (CD117)-ligand as the missing link? Immunol Today. 1994;15:111-114.
15. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol. 1994;55:1-96.
16. de Paulis A, Minopoli G, Arbustini E, et al. Stem cells factor is localized in, released from, and cleaved by human mast cells. J Immunol. 1999;163:2799-2808.
17. Columbo M, Horowitz EM, Botana LM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol. 1992;149:599-608.
18. Petersen LJ, Brasso K, Pryds M, Skov PS. Histamine release in intact human skin by monocyte chemoattractant factor-1, RAN-TES, macrophage inflammatory protein-1α, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J Allergy Clin Immunol. 1996;98:790-796.
19. Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983;71:177-183.
20. Haas N, Toppe E, Henz BM. Microscopic morphology of different types of urticaria. Arch Dermatol. 1998;134:41-46.
21. Lichtenstein LM, Osler AG. Study on the mechanism of hypersensitivity phenomena, IX: histamine release from human leukocytes by ragweed pollen antigen. J Exp Med. 1964;120:507-530.
22. Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol. 2000;106:567-572.
23. Sabroe RA, Fiebiger E, Francis DM, et al. Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002;110:492-499.
24. Ma Y, Carter E, Wang X, Shu C, McMahon G, Longley BJ. Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells. J Invest Dermatol. 2000;114:392-394.